Silicon slump puts IPOs on ice | PitchBook News Summary

1. Key Themes

Theme 1: Semiconductor Stock Slump Threatens Chip Startup IPO Pipeline

The slide in public semiconductor stocks is creating a pricing disconnect between private chip companies and public market buyers, putting late-2026 and early-2027 IPO plans at risk.

"The sell-off repriced the exit pipeline, so every chip startup that marked itself against Q2's peak now faces a bid-ask gap with public buyers, which historically resolves as deferral rather than cancellation." — PitchBook senior analyst Harrison Rolfes

The Nasdaq slipped 3.2% over five days, paring its 2026 gain to 7.1%, with Micron, Sandisk, Nvidia, and AMD all declining. The post-IPO performance of Cerebras Systems — valued at $56.4 billion at its May IPO but down 31.1% since — illustrates the risk for the companies still in queue.

Theme 2: PE's Wealth Management Acquisition Spree Is Intensifying

Investcorp's acquisition of Berger Financial Group (a $3B AUM, 3,800-client RIA) signals that PE firms continue to aggressively pursue wealth management consolidation, even against fierce competition.

"RIAs control around $9.8 trillion, up from $6.6 trillion in 2019, equivalent to an annual growth rate of 12%... $30.3 billion has gone into wealth management deals this year, versus a record of nearly $36 billion in 2025."

The RIA roll-up playbook is explicit: Investcorp's Vitali Bourchtein said "the plan is to build Berger into 'another sizable player' by rolling up smaller RIAs." Bain Capital and The Carlyle Group are simultaneously battling over Wealth Enhancement Group in a ~$7 billion deal, underscoring intensifying competition for quality targets.

Theme 3: PE Accelerating Into Upstream Oil & Gas

Private equity is actively deploying capital into upstream oil and gas, driven by supply security concerns and a retreat by capital-disciplined public producers.

"PE is on a buying spree in upstream oil and gas, and analyst Benny Wong says supply security concerns and capital-disciplined public producers are creating a window sponsors shouldn't ignore."

This is further evidenced by Apollo Global Management committing $1.5 billion into Singapore-based Keppel's oil rig fund, and Strategic Value Partners acquiring a minority stake in Ohio-based natural gas power plant South Field Energy.

Theme 4: Mega-Fund PE Underperformance vs. Smaller Peers

Despite a clear and persistent performance gap, the largest LPs continue to allocate heavily to mega-funds — a structural anomaly the newsletter flags explicitly.

"The biggest PE managers have underperformed smaller peers since 2015 — yet the largest LPs keep writing them mega-checks, and the structural reasons why aren't going away."

This creates an ongoing inefficiency for investors willing to do the work to identify top-performing smaller and mid-market managers — a theme reinforced by PitchBook's annual Manager Performance Rankings, which evaluate fund families across strategies.

Theme 5: AI Is Disrupting How Direct Lenders Underwrite Software Deals

European direct lender Hayfin is sitting out software investments from its newly raised €15 billion flagship fund because AI has fundamentally changed how it assesses company durability in the sector.

"European direct lender Hayfin has yet to complete a software investment from its recently raised €15 billion ($17.08 billion) flagship fund, saying AI has changed how it assesses companies in the sector."

This is a leading indicator of a broader credit market reassessment of software businesses — relevant not just for lenders but for founders seeking debt financing and investors underwriting software valuations.

2. Contrarian Perspectives

Perspective 1: Chinese Semiconductor Competition Is a Structural Threat, Not Just a Headline Risk

The conventional narrative treats US-China chip tension as a geopolitical overhang. This edition presents evidence that China is already competing effectively in capital markets. CXMT's Shanghai IPO raised a domestic record of $8.6 billion in proceeds in a single day — more than most US chip startups are worth.

"A major headwind for US semiconductor stocks was Chinese chipmaker CXMT's Shanghai IPO on Monday, which raised a domestic record of $8.6 billion in proceeds. Wall Street has been worried that Chinese peers could become a significant threat to US chipmakers."

The implication: the threat isn't future — it's present, and it's affecting public market pricing today, which cascades into private market valuations.

Perspective 2: Chip Startup IPO Delays Are Deferrals, Not Cancellations — The Pipeline Remains Intact

While the headline frames the situation as "IPOs on ice," the actual analyst framing is more nuanced and bullish on the long-term pipeline.

"The sell-off repriced the exit pipeline, so every chip startup that marked itself against Q2's peak now faces a bid-ask gap with public buyers, which historically resolves as deferral rather than cancellation."

For investors in private chip startups (SambaNova at $11B, Etched at $10.3B), this means the exit path is intact but timing has shifted — which may create secondary market pricing opportunities, not permanent impairment.

Perspective 3: Wealth Management Remains Attractive Despite "Fierce Competition"

The consensus view might be that the wealth management space is now too crowded and expensive for PE entry. Investcorp's Bourchtein pushes back directly.

"The market's size and fragmentation, plus favorable demographics, make wealth management attractive, he said, despite fierce competition from other PE firms and strategic buyers."

With RIA AUM growing at 12% annually from $6.6T to $9.8T since 2019, and thousands of sub-scale firms still operating independently, the roll-up runway remains long even as headline deal sizes and valuations climb.

3. Companies Identified

Cerebras Systems

Description: AI chip company; went public in May 2026
Why mentioned: Case study of a chip startup IPO gone sideways — illustrating the risks facing the current pipeline
Quote: "Cerebras Systems was valued at $56.4 billion in its May IPO. Cerebras' stock surged in early trading but has since dropped by 31.1%."

SambaNova Systems

Description: Private AI chip company
Why mentioned: Highest-valued still-private chipmaker; a key IPO candidate at risk of delay
Quote: "Among still-private chipmakers, SambaNova Systems carries the highest valuation at $11 billion after a recent new funding round."

Etched

Description: Private AI chip startup
Why mentioned: Second-highest-valued private chipmaker; IPO candidate
Quote: "…followed by Etched at $10.3 billion."

CXMT

Description: Chinese semiconductor manufacturer
Why mentioned: Its record-breaking $8.6B Shanghai IPO is a direct catalyst for the US chip stock sell-off
Quote: "Chinese chipmaker CXMT's Shanghai IPO on Monday…raised a domestic record of $8.6 billion in proceeds."

Investcorp

Description: $62 billion alternatives manager
Why mentioned: Made its first US wealth management acquisition (Berger Financial Group) as part of an RIA roll-up strategy
Quote: "The deal makes Investcorp the latest PE firm to chase the wealth management boom."

Berger Financial Group

Description: RIA managing $3B across 3,800 clients in five states
Why mentioned: Acquisition target; case study for mid-market RIA valuations (11–16x adjusted EBITDA)
Quote: "Berger manages $3 billion and serves 3,800 clients across offices in Minnesota, Arizona, Vermont, Maine and Illinois."

Wealth Enhancement Group

Description: Large RIA firm
Why mentioned: Subject of a contested ~$7B acquisition battle between Bain Capital and The Carlyle Group
Quote: "Bain Capital and The Carlyle Group are currently battling to acquire Wealth Enhancement Group in a deal valued at around $7 billion."

Hayfin

Description: European direct lender with a €15B flagship fund
Why mentioned: Pausing software investments because AI has changed its underwriting framework — a significant market signal
Quote: "Hayfin has yet to complete a software investment from its recently raised €15 billion ($17.08 billion) flagship fund, saying AI has changed how it assesses companies in the sector."

Safe Superintelligence

Description: AI specialist startup
Why mentioned: Received a $5 billion investment from Nvidia as part of a hardware partnership
Quote: "Nvidia will invest $5 billion in AI specialist Safe Superintelligence as part of a partnership that will give the company access to Nvidia hardware."

Fish Audio

Description: AI voice platform (text-to-speech, voice cloning, voice agents)
Why mentioned: Raised a $52M seed round — notable deal size for seed stage
Quote: "Fish Audio…raised a $52 million seed round led by Coreline Ventures and Capital Today."

Curium / Lantheus

Description: Curium is a radiopharmaceutical company backed by Capvest Partners; Lantheus is a publicly traded radiopharmaceutical company
Why mentioned: Potential $7B take-private deal signals PE interest in the radiopharmaceutical sector
Quote: "Capvest Partners-backed Curium is in talks to acquire fellow radiopharmaceutical company Lantheus in a $7 billion take-private deal."

GrubMarket

Description: E-commerce platform for groceries
Why mentioned: Confidentially filed for a US IPO — a notable exit signal in the consumer/food tech space
Quote: "GrubMarket…confidentially filed for a US IPO."

4. People Identified

Harrison Rolfes

Description: Senior analyst at PitchBook
Why mentioned: Provided the key analytical framing on chip startup IPO delays
Quote: "The sell-off repriced the exit pipeline, so every chip startup that marked itself against Q2's peak now faces a bid-ask gap with public buyers, which historically resolves as deferral rather than cancellation."

Vitali Bourchtein

Description: Managing Director, North American Private Equity, Investcorp
Why mentioned: Articulated the strategic rationale for the Berger acquisition and Investcorp's broader RIA roll-up ambitions
Quote: "The plan is to build Berger into 'another sizable player' by rolling up smaller RIAs."

Benny Wong

Description: PitchBook analyst covering energy and PE
Why mentioned: Identified the structural opportunity for PE in upstream oil and gas
Quote: "Analyst Benny Wong says supply security concerns and capital-disciplined public producers are creating a window sponsors shouldn't ignore."

Helen Toner

Description: Former OpenAI board member
Why mentioned: Raised an alarm about fundamental gaps in AI safety — the industry doesn't yet know how to prevent models from going rogue
Quote: "We have to get out of this rut where testing models before they're released is the main focus… The best engineers in the world still don't know how to stop AI models from going rogue."

5. Operating Insights

1. Time your IPO window against public comparables, not just internal milestones. The Cerebras post-IPO decline (-31.1%) and the broader semiconductor sell-off demonstrate that private companies marking themselves against peak public comps will face a bid-ask gap when they actually go to market. Founders and CFOs should model IPO pricing against current — not peak — public multiples, and build in a 6–12 month timing buffer.

"The sell-off repriced the exit pipeline, so every chip startup that marked itself against Q2's peak now faces a bid-ask gap with public buyers."

2. For RIA acquirers, act before the window closes — but expect to pay 11–16x EBITDA. The RIA consolidation wave is real and accelerating: $30.3B in wealth management deals in 2026 alone, approaching last year's record $36B. Mid-market firms like Berger (at $3B AUM) remain available, but valuations are established and competitive. Buyers should move quickly on identified targets and underwrite roll-up economics from day one.

"Wealth management firms of Berger's size can expect to trade in the region of 11 to 16 times adjusted EBITDA."

6. Overlooked Insights

1. Female founder deal share has been quietly declining since 2021. This data point — buried in the Chart of the Day — shows a meaningful and sustained reversal. Startups with at least one female founder fell from 21.4% of deal count in 2021 to ~17.5% by Q3 2025. Female-only founded companies peaked near 7% in 2023 and have since dropped to ~5.8%. This trend runs counter to public commitments by many institutions and may represent a reallocation of LP pressure and attention toward AI-focused deals.

"Startups with at least one female founder accounted for 21.4% of deal count in 2021 but fell to about 17.5% by Q3 2025."

2. Prediction markets are now influencing (and being resisted in) FDA drug approval betting — a regulatory flashpoint with real biotech implications. Kalshi and Polymarket now allow traders to wager on FDA drug approvals. Cancer patients are actively pushing back. This creates a nascent but material risk for biotech companies: public prediction market odds on their drugs could influence investor sentiment, analyst coverage, and even patient behavior — before the FDA has ruled.

"Cancer patients are pushing back on prediction markets hosting bets on whether their own treatments will succeed, now that Kalshi and Polymarket let traders wager on FDA drug approvals."